Outcome Of The Meeting Of The Board Of Directors Held On Thursday, 5Th February, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Pratiksha Chemicals approved unaudited financial results for the quarter ended 31 December 2025. Revenue from operations surged to Rs 716.03 lakhs in Q3 FY26, up sharply from Rs 167.91 lakhs in the same quarter last year. However, profit for the quarter collapsed to just Rs 9.27 lakhs (EPS of Rs 0.17) compared to Rs 552.63 lakhs (EPS of Rs 9.92) a year ago, largely due to a Rs 86.62 lakh extraordinary impairment provision. The impairment follows shareholder approval via EGM for the sale of a significant portion of the company's assets. The statutory auditor issued a qualified opinion, flagging that gratuity and leave encashment are being accounted for on a cash basis instead of as required by Ind AS-19. Total expenses stood at Rs 634.37 lakhs for the quarter.
Despite strong revenue growth, near-zero quarterly profit and a qualified audit opinion are negative signals for shareholders. The asset sale and related impairment suggest the company is restructuring or shrinking its business, which could weigh on the stock in the short term.